Brain fog after lymphoma: study probes lasting cognitive effects of chemotherapy
NCT ID NCT07652476
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at thinking skills, memory, and quality of life in people who are 3 to 5 years past successful treatment for Hodgkin lymphoma or certain types of B-cell lymphoma. Participants take a series of tests and questionnaires once during a regular follow-up visit. The goal is to understand how common cognitive problems are after treatment and what factors might be linked to them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If this study finds clear patterns of cognitive decline, it could lead to better monitoring and support for lymphoma survivors.
What could go wrong
This is an observational study with only 100 participants, so results may not apply to all survivors. It does not test any treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLASSIC HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinica di Ematologia, AOU Ospedali Riuniti
Ancona, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano
Aviano, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ematologia - AOU Policlinico Giaccone
Palermo, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ematologia - Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda
Milan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SC Ematologia - ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
U.O.C Ematologia - IRCCS Istituto Tumori Giovanni Paolo II
Bari, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
U.O.C. Ematologia Ospedale Civile di Legnano - ASST Ovest Milanese
Legnano, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••